Vaxcyte, Inc. (PCVX)
57.34
+1.17
(+2.08%)
USD |
NASDAQ |
Feb 19, 16:00
57.34
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Market Cap : 7.506B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 152.69B |
| Novavax, Inc. | 1.499B |
| Moderna, Inc. | 19.42B |
| Rhythm Pharmaceuticals, Inc. | 6.883B |
| Sutro Biopharma, Inc. | 166.60M |
Market Cap Related Metrics
| PEG Ratio | -2.234 |
| Price to Book Value | 2.595 |
| Price | 57.34 |
| Earnings Yield | -8.58% |
| PEGY Ratio | -2.234 |